Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-167-8 | CAS number: 305-72-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Not specified
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- In the study investigations are described which cannot be subsumed under a testing guideline, but which are nevertheless well documented and scientifically acceptable.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 001
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- In the study investigations are described which cannot be subsumed under a testing guideline, but which are nevertheless well documented and scientifically acceptable.
- GLP compliance:
- no
- Test type:
- other: Moving average method of Gad and Weil (1989)
- Limit test:
- no
Test material
- Reference substance name:
- Disodium 2-oxoglutarate
- EC Number:
- 206-167-8
- EC Name:
- Disodium 2-oxoglutarate
- Cas Number:
- 305-72-6
- Molecular formula:
- C5H6O5.2Na
- IUPAC Name:
- disodium 2-oxopentanedioate
- Test material form:
- not specified
- Details on test material:
- a-ketoglutarate (a-ketoglutaric acid, disodium salt; a-KG)was purchased from Sigma, St. Louis, USA
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Division of Pharmacology and Toxicology, Defence Research and Development Establishment, Jhansi Road, Gwalior 474002 (M.P.), India
- Females nulliparous and non-pregnant: not indicated
- Age at study initiation: not indicated
- Weight at study initiation: Females: 150-200 g
Males: 150-200 g (males between 350–380 g were used for physiological studies)
- Fasting period before study: overnight
- Housing: bedding of rice husk in polypropylene cages
- Diet: standard pellet diet (Amrut Feeds, Pranav Agro, Delhi, India) ad libitum
- Water: ad libitum
- Acclimation period: not specified
ENVIRONMENTAL CONDITIONS
- Temperature (°C): not specified
- Humidity (%): not specified
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): not specified
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- physiological saline
- Details on oral exposure:
- VEHICLE: Physiological saline 0.9% Sodium Chloride
MAXIMUM DOSE VOLUME APPLIED: < 10 ml
- Doses:
- 2000, 4000, 5000, 10000 mg/kg bw
- No. of animals per sex per dose:
- 4 female, 4 male
Additionally 24 female and 32 male rats received only physiological saline (6 per sex) or 2000 mg/kg bw for haematology, biochemistry, organ/body weight index, histology and physiological studies - Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: not specified
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,
- Two rats each of the control group (treated with phisiological saline) and six each receiving 2000 mg/kg test item were sacrificed 1 h, 24 h and 7 days after treatment for haematology, biochemistry, organ/body weight index (organ weight × 100/animal body weight) and histology.
- Hematology: standards hematological analysis was performed at various time intervals after blood collections from the retro-orbital plexus under
light ether anaesthesia.
- Biochemistry: Serum alkaline phosphatase (ALP), ¿-glutamyl transferase (¿-GT), lactate dehydrogenase (LDH), glutamyl pyruvate transaminase (GPT), glutamyl oxaloacetate transaminase (GOT), protein, glucose, creatinine, urea, cholesterol and inorganic phosphorus were measured by commercial diagnostic kits from Ranbaxy Laboratories/Merck India/Miles India.
Na+ and K+ were measured by flame photometry (Systronics 128, India).
- Urine analysis: after 24 h and 7 days of treatment urine samples were pooled and examined for pH, nitrite proteins, glucose,ketones, urobilinogen, bilirubin and haemoglobin using the Combur-8-Test (Boehringer Mannheim, Germany).
-Physiology: Rats were anaesthetized with urethane (1.6 g kg-1) intraperitoneally and various physiological parameters were recorded at different
time intervals. Rectal temperature was also recorded.
Parameters measured: respiratory rate, blood pressure, mean arterial pressure, heart rate. Neuromuscular transmision was meassured on the gastracnemius muscle by estimulation of the sciatic nerve. - Statistics:
- The data were analysed by one-way ANOVA followed by Dunnett’s test using SigmaStat software (Jandel Scientific Inc., USA).
Statistical significance was estimated at the 5% level.
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 7 100 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All the animals receiving 10 g/kg bw died within 2–3 h.
- Clinical signs:
- other: No signs or symptoms of toxicity on surviving animals
- Gross pathology:
- Performed on separate animals that received a dose of 2000 mg/kg bw and were sacrificed after 1 h, 24 h and 7 days of treatment.
Organ/body weight index for vital organs did not show any significant changes. - Other findings:
- Haematology, biochemistry, physiology and histology of animals that received 2000mg/kg bw did not show significant changes.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- alpha-Ketoglutarat (CAS 305-72-6) has an LC50 of 7100 mg/kg by oral route in the rat.
In conclusion the substance does not need to be classified acc. to the Globally Harmonized Classification System (GHS) and acc. to the current EU Regulation on classification, labeling and packaging (CLP) (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.